Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News

September 20, 2013— The Mount Sinai Medical Center is participating in the nationwide Absorb III clinical trial testing ...

Home September 20, 2013
Home
News

September 17, 2013 — In a significant milestone toward obtaining additional key regulatory approvals for the Synergy dru ...

Home September 17, 2013
Home
News

September 9, 2013 — Cardiac stents to open blocked heart arteries and reduce chest pain have been used for decades ...

Home September 09, 2013
Home
Feature

August 28, 2013 — Effective Oct. 1, Cook Medical’s Zilver PTX drug-eluting peripheral stent qualifies for new-technology ...

Home August 28, 2013
Home
News

August 28, 2013 — According to Millennium Research Group (MRG), efforts to streamline the regulatory approval process in ...

Home August 28, 2013
Home
News

August 26, 2013 — Boston Scientific Corp. has completed enrollment in the SuperNOVA trial – a global, single arm ...

Home August 26, 2013
Home
News

August 19, 2013 — Cook Medical is again shipping its Zilver PTX drug-eluting peripheral stent to medical centers in the ...

Home August 19, 2013
Home
News

August 16, 2013 — Patient enrollment has been initiated in a post-market registry for the Combo Dual Therapy Stent to ...

Home August 16, 2013
Home
News

August 5, 2013 — AstraZeneca announced results from a new sub-analysis of the PLATO study that evaluated the incidence ...

Home August 05, 2013
Home
News

August 1, 2013 — InspireMD Inc. said the first patient has been enrolled in the Master II IDE clinical trial to evaluate ...

Home August 01, 2013
Home
News

July 18, 2013 — Abbott announced that it has entered into an agreement to purchase IDEV Technologies, a privately held ...

Home July 18, 2013
Home
Technology

July 12, 2013 — Micell Technologies Inc. received CE mark approval for its MiStent sirolimus-eluting absorbable polymer ...

Home July 12, 2013
Home
News

July 1, 2013 — Primary end-point results from the BIOFLOW-II clinical study demonstrating the non-inferiority of the ...

Home July 01, 2013
Home
News

June 24, 2013 — Final six and 12-month results of the DIRECT first-in-man clinical study were presented by study ...

Home June 24, 2013
Home
News

June 13, 2013 — Tryton Medical Inc. announced that the Nordic-Baltic Bifurcation Study Group will investigate the Tryton ...

Home June 13, 2013
Home
Subscribe Now